Site Editor

Soo Park, MD


Sophia McKinley, MD, EdM, on the Role of Adjuvant Immunotherapy for High-Risk Cutaneous Melanoma

Posted: Tuesday, April 23, 2024

Sophia McKinley, MD, EdM, of Massachusetts General Hospital, discusses recurrence of cutaneous melanoma after adjuvant immunotherapy for patients with high-risk, resected disease, differences in overall survival based on the type of immunotherapy used, and the focus of future clinical trials for this patient population.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.